References
- Kaplan R., Haussler M., Deffos L., Bonett, Pale C. Y. C. The role of 1,25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 1977; 59: 756–60
- Gray R., Wilz D., Caldas A., Lemann J. The importance of phosphate in regulating plasma, 1,25(OH)2-vitamin D levels in humans: studies in healthy subjects, in calcium-stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 1977; 45: 299–306
- Tanaka Y., DeLuca H. Stimulation of 24,25-dihydroxy-vitamin D3 production by 1,25-dihydroxyvitamin D3. Science 1974; 183: 1198–200
- Boyle J., Gray R., DeLuca H. Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol and 21,25-dihydroxycholecalciferol. Proc Natl Acad Sci USA 1971; 68: 2131–4
- Garabedian M., Holick M., DeLuca H., Boyle I. Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci USA 1972; 69: 1673–6
- Tanaka Y., DeLuca H., Ikekawa N., Morisaki M., Koisumi N. Determination of stereochemical configuration of the 24-hydroxyl group of 24,25-dihydroxyvitamin D3. Arch Biochem Biophys 1975; 170: 620–6
- Bordjer P., Rasmussen H., Marie P., Miraret L., Gueris J., Ryckwaert A. Vitamin D metabolites and bone mineralisation in man. J Clin Endocrinol Metab 1978; 46: 284–94
- Parviainen M., Savolainen K., Korhonen P., Alhava E., Visakorpi J. An improved method for routine determination of vitamin D and its hydroxylated metabolites in serum from children and adults. Clin Chim Acta 1981; 114: 233–47
- Haussler M., Bursac K., Bone H., Pak C. Increased circulating 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism. Clin Res 1975; 23: 322A
- Bone H. G., III, Zerwekh J. E., Haussler M. R., Pak C. Y. Effect of parathyroidectomy on serum 1,25-dihydroxyvitamin D and intestinal calcium absorption in primary hyperparathyroidism. J Clin Endocrinol Metab 1979; 48: 877–9
- Canterbury J., Gavellas G., Bourgoignie J., Reiss E. Metabolic consequences of oral administration of 24,25-dihyd-roxy-cholecalciferol to uremic clogs. J Clin Invest 1980; 65: 571–6
- Holmlund D., Boquist L., Larsson S., Lorentzon R. Influence of 1,25-dihydroxycholecalciferol on parathyroid activity in patients with primary hyperparathyroidism. Acta Chir Scand 1979; 145: 27–33
- De Luca H. Metabolism and molecular mechanism of action of vitamin D: 1981. Biochem Soc Trans 1982; 10: 147–58
- Fraser D. Regulation of the metabolism of vitamin D. Physiol Rev 1980; 60: 551–613
- Rasmussen H., Bordier P. Vitamin D and bone. Metab Bone Dis Relat Res 1978; 1: 7–13
- Lore F., Di Cairano G. Studies on the hydroxylation of vitamin D in man. Ann Med Interne (Paris) 1986; 137: 206–8
- Gordeladze, Mortensen B., Nordal K., Halse J., Dahl E., Aksnes L., Gautvik K. The effect of parathyroid hormone (PTH) and 24,25-dihydroxy-vitamin D3 on adenyl cyklase of iliac crest biopsies: Diagnostic and prognostic tool for evaluation and treatment of uremic patients. Scand J Clin Lab Invest 1987; 47(Suppl 186)13–20